Paying users zone. Data is covered by hidden.

  • Get 1 month access to Gilead Sciences Inc. for $17.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Gilead Sciences Inc. (GILD)


Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Difficulty: Beginner

Gilead Sciences Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Accounts payable hidden hidden hidden hidden hidden
Accrued government and other rebates hidden hidden hidden hidden hidden
Compensation and employee benefits hidden hidden hidden hidden hidden
Accrued payment for marketing-related rights acquired from Japan Tobacco hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Other accrued expenses hidden hidden hidden hidden hidden
Other accrued liabilities hidden hidden hidden hidden hidden
Current portion of long-term debt and other obligations, net hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Long-term debt, net, excluding current portion hidden hidden hidden hidden hidden
Long-term income taxes payable hidden hidden hidden hidden hidden
Other long-term obligations hidden hidden hidden hidden hidden
Long-term liabilities hidden hidden hidden hidden hidden
Total liabilities hidden hidden hidden hidden hidden
Equity component of currently redeemable convertible notes hidden hidden hidden hidden hidden
Preferred stock, par value $0.001 per share; none outstanding hidden hidden hidden hidden hidden
Common stock, par value $0.001 per share hidden hidden hidden hidden hidden
Additional paid-in capital hidden hidden hidden hidden hidden
Accumulated other comprehensive income hidden hidden hidden hidden hidden
Retained earnings hidden hidden hidden hidden hidden
Total Gilead stockholders’ equity hidden hidden hidden hidden hidden
Noncontrolling interest hidden hidden hidden hidden hidden
Total stockholders’ equity hidden hidden hidden hidden hidden
Total liabilities and stockholders’ equity hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Gilead Sciences Inc.’s current liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 and from 2017 to 2018.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Gilead Sciences Inc.’s long-term liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 but then declined significantly from 2017 to 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Gilead Sciences Inc.’s total liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 but then slightly declined from 2017 to 2018 not reaching 2016 level.
Total Gilead stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Gilead Sciences Inc.’s total Gilead stockholders’ equity as a percentage of total liabilities and stockholders’ equity declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.